Wordt geladen...
A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resection
BACKGROUND: Bevacizumab is active in the treatment of metastatic colorectal cancer (mCRC). However, efficacy of bevacizumab has predominantly been evaluated on selected patients with relatively good performance status and minor comorbidities. We evaluated the efficacy and safety of bevacizumab in un...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4085307/ https://ncbi.nlm.nih.gov/pubmed/25061319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S63739 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|